m_keykhaei Profile Banner
Mohammad Keykhaei, MD, MPH Profile
Mohammad Keykhaei, MD, MPH

@m_keykhaei

Followers
2K
Following
17K
Media
71
Statuses
1K

PGY-1 IM Resident @DOM_UCLA|Postdoc Research Fellow @HopkinsHeart|Editorial Board @PLOSONE, @BMC_GPH, @FrontPharmacol |🏊🏼‍♂️🎼📚✈️

Los Angeles, CA
Joined April 2021
Don't wanna be here? Send us removal request.
@m_keykhaei
Mohammad Keykhaei, MD, MPH
5 months
Speechless is what I am! A dream came true! I matched in Internal Medicine Residency at @DOM_UCLA ! Immensely grateful to my mentors, Drs. David Kass, Virginia Hahn, and @ArdehaliHossein. Can't wait to start this journey! @uclaimchiefs #Match2025 @TheNRMP @UCLAHealth #MedTwitter
Tweet media one
79
17
949
@m_keykhaei
Mohammad Keykhaei, MD, MPH
21 hours
RT @HemostasisToday: BEHNOOD BIKDELI (@bbikdeli) and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant T….
0
5
0
@grok
Grok
2 days
Join millions who have switched to Grok.
126
241
2K
@m_keykhaei
Mohammad Keykhaei, MD, MPH
21 hours
RT @rblument1: Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Di….
jacc.org
0
4
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
23 hours
RT @gcfmd: 🌏 Very large global burden of HF related mortality. 🚨 Rising age-adjusted HF ☠️ in many regions . 🛟 An estimated 1.2 million dea….
0
7
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
3 days
RT @gcfmd: What updated thresholds for statin use could mean for patients - STAT. ⁦@HeartDocSadiya⁩ ⁦@JAMACardio⁩ ⁦@kewatson⁩ ⁦@rblument1⁩….
Tweet card summary image
apple.news
It’s a math problem with life-and-death consequences.
0
4
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
3 days
RT @bbikdeli: A recent study in @ThrombosisRese1 reported on #VTE associated litigation after 🦴surgery: In the Edi….
0
4
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
4 days
RT @bbikdeli: Lp(a) ⬆️the risk of ASCVD, but how about #VTE??🤔. 🚨We summarize the existing pathophys & epidemiological data in @TH_Journal….
0
20
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
4 days
RT @DOM_UCLA: Fantastic news! We’re proud to announce that UCLA Health is once again ranked the No. 1 health system in California and Los A….
0
4
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
6 days
RT @gcfmd: How many clinicians believe having 4 Class 1 guideline-recommended, disease modifying, ☠️⬇️ medical therapies for HFrEF means:….
0
9
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
7 days
RT @ArashNargesi: Excited to attend #ESCCongress 2025 in Madrid next week, where I will share our studies on:.- LLM agents.- Multimodal fou….
0
2
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
7 days
RT @gcfmd: HFrEF. Q-GDMT (ARNI+BB+MRA+SGLT2i). 🛟 Extend median overall survival by 7-11 YEARS. Self-pay cash price all 4 💊. $121 per month….
0
38
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
8 days
RT @DOM_UCLA: Our 2025-2026 DMPG physician onboarding program is officially underway! This unique yearlong curriculum equips new faculty wi….
0
1
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
10 days
RT @gcfmd: @kaulcsmc @JACCJournals Very nicely done. All the more stunning that despite the clinical trial evidence, regulatory decisions,….
0
1
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
10 days
RT @gcfmd: It has proved to be so very difficult to improve CV outcomes in patients receiving maintenance dialysis. Spironolactone versus p….
Tweet card summary image
thelancet.com
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared...
0
8
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
11 days
RT @bbikdeli: Thank you @EricTopol for interest in our @ESC_Journals Editorial. The OR an interesting look at markers of vascular aging sho….
Tweet card summary image
academic.oup.com
This editorial refers to ‘Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study’, by R.M. Bruno et al., https://doi.org/10.1093/eurhear
0
6
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
11 days
RT @gcfmd: During the time period that so many effective therapies became available which could prevent incident HF and improve outcomes in….
0
9
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
11 days
RT @gcfmd: Worldwide red alert🚨. HF attributed ☠️ ⤴️⤴️⤴️. Critical to prioritize prevention and improved treatment of HF globally . Effecti….
0
7
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
12 days
RT @datsunian: A 🔥 year for research in @UCLAHealth #bruinhearts #cardioonc!!. Two PhDs 🏅 to our team from the @uclaCVfellows #STAR track:….
0
9
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
14 days
RT @gcfmd: @MrWBond @Shamsan_ha @SS_cardiol @CircHF For a patient with mild symptoms and without higher risk features one may elect to take….
0
2
0
@m_keykhaei
Mohammad Keykhaei, MD, MPH
14 days
🎉Excited to share our study on the multi-omic signature of HFpEF myocardium has been accepted for an oral presentation at #AHA25! Grateful to my mentors (@VirginiaSHahnMD, and Dr. David A. Kass) for their support. @MasihTajdini @navidkoleini @AHAScience @DOM_UCLA @uclaimchiefs
Tweet media one
Tweet media two
8
4
91